CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow has resigned from the Board of Directors, effective December 30, 2008, citing disagreements with the Board. The Company has filed a copy of Mr. Barlow’s resignation with the Securities Exchange Commission today as an exhibit to a current report on Form 8-K
